In a report published Monday, Jefferies & Company reiterated its Buy rating on Warner Chilcott WCRX, but lowered its price target from $19.00 to $15.00.
Jefferies noted, “WCRX blew away 3Q EPS and again reduced OpEx/raised EPS guidance. Mgmt has done a great job cutting costs, though it's unclear how much deeper it can go. 2013 will likely be challenging given revenue declines, but management continues to highlight its secretive pipeline. Further, while no BD activity has materialized, mgmt's commentary around Derm expansion is intriguing. We lower PT to $15 to reflect payment of $4 special dividend.”
Warner Chilcott closed on Friday at $11.67.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in